Australia’s medical cannabis market is on a continuous incline, with 6,000+ patients gaining approval for the country’s Special Access Scheme (SAS) Category B pathway as of September. This indicates...

The Narcotic Drugs Regulations 2016 was recently tweaked under the Narcotics Drugs Amendment (Cannabis) Regulations 2018 (Cth). Based on the changes, Australian producers will be able to export medicinal...